Ropivacaine has the potential to relieve PM2.5‑induced acute lung injury

Zuo,Rui; Li,Xin-Yu; He,Yong-Guan

doi:10.3892/etm.2022.11486

Ropivacaine has the potential to relieve PM2.5‑induced acute lung injury

Authors:
- Rui Zuo
- Xin-Yu Li
- Yong-Guan He
View Affiliations

Affiliations: Department of Anesthesiology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei 445000, P.R. China
Published online on: July 1, 2022 https://doi.org/10.3892/etm.2022.11486
Article Number: 549
Copyright: © Zuo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ropivacaine is a commonly used local anesthetic in the clinic due to its low toxicity to the cardiovascular system or central nervous system, good tolerance and high clearance rate. The present study intended to investigate the effect of ropivacaine on PM2.5‑induced acute lung injury (ALI) and reveal the underlying mechanism. After ropivacaine exposure, cell viability, oxidative stress and inflammation in PM2.5‑induced BEAS‑2B cells were assessed by Cell Counting Kit‑8 and DCFH‑DA staining, corresponding commercial kits and ELISA, respectively. The effects of ropivacaine on the expression of MMP9 and MMP12 and the proteins related to NLRP3/Caspase‑1 signaling were then determined by western blot and reverse transcription‑quantitative PCR analyses. In addition, NLR family pyrin domain containing 3 (NLRP3) agonist monosodium urate (MSU) was used to treat BEAS‑2B cells followed by ropivacaine treatment and the effects on the above‑mentioned cellular behaviors were determined again. The results indicated that the viability of BEAS‑2B cells was decreased after PM2.5 induction, accompanied by aggravated oxidative stress and inflammation. However, ropivacaine alleviated oxidative stress and inflammation in PM2.5‑induced BEAS‑2B cells in a dose‑dependent manner. Ropivacaine was also indicated to decrease the expression levels of NLRP3/Caspase‑1 signaling‑related proteins in PM2.5‑induced BEAS‑2B cells. Furthermore, cell viability was decreased, while oxidative stress and inflammatory response were aggravated, in PM2.5‑induced BEAS‑2B cells treated with MSU. In summary, the present results implied that ropivacaine exerted protective effects on PM2.5‑induced ALI, and this effect may be related to NLRP3/Caspase‑1 signaling.

View Figures

View References

1	Kumar V: Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Front Immunol. 11(1722)2020.PubMed/NCBI View Article : Google Scholar
2	Rezoagli E, Fumagalli R and Bellani G: Definition and epidemiology of acute respiratory distress syndrome. Ann Transl Med. 5(282)2017.PubMed/NCBI View Article : Google Scholar
3	Zeng M, Sang W, Chen S, Chen R, Zhang H, Xue F, Li Z, Liu Y, Gong Y, Zhang H and Kong X: 4-PBA inhibits LPS-induced inflammation through regulating ER stress and autophagy in acute lung injury models. Toxicol Lett. 271:26–37. 2017.PubMed/NCBI View Article : Google Scholar
4	Gu LZ, Sun H and Chen JH: Histone deacetylases 3 deletion restrains PM2.5-induced mice lung injury by regulating NF-κB and TGF-β/Smad2/3 signaling pathways. Biomed Pharmacother. 85:756–762. 2017.PubMed/NCBI View Article : Google Scholar
5	Zhou Y, Yang TB, Wei J, Zeng C, Li H, Yang T and Lei GH: Single-dose intra-articular ropivacaine after arthroscopic knee surgery decreases post-operative pain without increasing side effects: A systematic review and meta-analysis. Knee Surg Sports Traumatol Arthrosc. 24:1651–1659. 2016.PubMed/NCBI View Article : Google Scholar
6	Piegeler T, Schläpfer M, Dull RO, Schwartz DE, Borgeat A, Minshall RD and Beck-Schimmer B: Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase. Br J Anaesth. 115:784–791. 2015.PubMed/NCBI View Article : Google Scholar
7	Lv H, Cheng Q, Li Y, Zhang Y, Chen J and Chen W: The protective effects of ropivacaine against high glucose-induced brain microvascular endothelial injury by reducing MMPs and alleviating oxidative stress. Neurotox Res. 39:851–859. 2021.PubMed/NCBI View Article : Google Scholar
8	Patel M, Chignalia AZ, Isbatan A, Bommakanti N and Dull RO: Ropivacaine inhibits pressure-induced lung endothelial hyperpermeability in models of acute hypertension. Life Sci. 222:22–28. 2019.PubMed/NCBI View Article : Google Scholar
9	Wu L, Li L, Wang F, Wu X, Zhao X and Xue N: Anti-inflammatory effect of local anaesthetic ropivacaine in lipopolysaccharide-stimulated RAW264.7 macrophages. Pharmacology. 103:228–235. 2019.PubMed/NCBI View Article : Google Scholar
10	Blumenthal S, Borgeat A, Pasch T, Reyes L, Booy C, Lambert M, Schimmer RC and Beck-Schimmer B: Ropivacaine decreases inflammation in experimental endotoxin-induced lung injury. Anesthesiology. 104:961–969. 2006.PubMed/NCBI View Article : Google Scholar
11	Piegeler T, Dull RO, Hu G, Castellon M, Chignalia AZ, Koshy RG, Votta-Velis EG, Borgeat A, Schwartz DE, Beck-Schimmer B and Minshall RD: Ropivacaine attenuates endotoxin plus hyperinflation-mediated acute lung injury via inhibition of early-onset Src-dependent signaling. BMC Anesthesiol. 14(57)2014.PubMed/NCBI View Article : Google Scholar
12	Schley MT, Casutt M, Haberthür C, Dusch M, Rukwied R, Schmelz M, Schmeck J, Schüpfer GK and Konrad CJ: Long-acting local anesthetics attenuate FMLP-induced acute lung injury in rats. Anesth Analg. 109:880–885. 2009.PubMed/NCBI View Article : Google Scholar
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
14	Zou W, Wang X, Hong W, He F, Hu J, Sheng Q, Zhu T and Ran P: PM2.5 induces the expression of inflammatory cytokines via the Wnt5a/Ror2 pathway in human bronchial epithelial cells. Int J Chron Obstruct Pulmon Dis. 15:2653–2662. 2020.PubMed/NCBI View Article : Google Scholar
15	Zhao J, Li M, Wang Z, Chen J, Zhao J, Xu Y, Wei X, Wang J and Xie J: Role of PM2.5 in the development and progression of COPD and its mechanisms. Respir Res. 20(120)2019.PubMed/NCBI View Article : Google Scholar
16	Lin CI, Tsai CH, Sun YL, Hsieh WY, Lin YC, Chen CY and Lin CS: Instillation of particulate matter 2.5 induced acute lung injury and attenuated the injury recovery in ACE2 knockout mice. Int J Biol Sci. 14:253–265. 2018.PubMed/NCBI View Article : Google Scholar
17	Jia H, Liu Y, Guo D, He W, Zhao L and Xia S: PM2.5-induced pulmonary inflammation via activating of the NLRP3/caspase-1 signaling pathway. Environ Toxicol. 36:298–307. 2021.PubMed/NCBI View Article : Google Scholar
18	Huang X, Jiang J, Huang L, Ren Q, Gao X and Yu S: Ropivacaine prevents the activation of the NLRP3 inflammasome caused by high glucose in HUVECs. ACS Omega. 5:23413–23419. 2020.PubMed/NCBI View Article : Google Scholar
19	Yang L, Liu G and Li X, Xia Z, Wang Y, Lin W, Zhang W, Zhang W and Li X: Small GTPase RAB6 deficiency promotes alveolar progenitor cell renewal and attenuates PM2.5-induced lung injury and fibrosis. Cell Death Dis. 11(827)2020.PubMed/NCBI View Article : Google Scholar
20	Lee FY, Lee MS, Wallace CG, Huang CR, Chu CH, Wen ZH, Huang JH, Chen XS, Wang CC and Yip HK: Short-interval exposure to ambient fine particulate matter (PM2.5) exacerbates the susceptibility of pulmonary damage in setting of lung ischemia-reperfusion injury in rodent: Pharmacomodulation of melatonin. Biomed Pharmacother. 113(108737)2019.PubMed/NCBI View Article : Google Scholar
21	Yang J, Chen Y, Yu Z, Ding H and Ma Z: The influence of PM2.5 on lung injury and cytokines in mice. Exp Ther Med. 18:2503–2511. 2019.PubMed/NCBI View Article : Google Scholar
22	Greenlee KJ, Werb Z and Kheradmand F: Matrix metalloproteinases in lung: Multiple, multifarious, and multifaceted. Physiol Rev. 87:69–98. 2007.PubMed/NCBI View Article : Google Scholar
23	Chen GQ, Benthani FA, Wu J, Liang D, Bian ZX and Jiang X: Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis. Cell Death Differ. 27:242–254. 2020.PubMed/NCBI View Article : Google Scholar
24	Zhou Y, Zhang CY, Duan JX, Li Q, Yang HH, Sun CC, Zhang J, Luo XQ and Liu SK: Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages. Biomed Pharmacother. 121(109596)2020.PubMed/NCBI View Article : Google Scholar